Unit for Depression, Psychiatry
Aalborg, 9000, Denmark
NCT Number: NCT03676491
Insomnia is a common sleep disorder for patients with depression. This has a major impact on the quality of life for the individual.
The aim is to investigate, whether music intervention is effective in
1. improving sleep quality, 2. reducing symptoms of depression and 3. improving quality of life
Participants use a sound pillow and selected music in the The Music Star app at home as a sleep aid in 4 weeks.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Not applicable
Aalborg, 9000, Denmark
Depression is a common health problem in Denmark with a prevalence for depression of 17-18%. Depression has serious personal and social consequence. Sleep disorders are common in patients with depression. Resolving sleep disturbances in depression may prevent worsening of symptoms and relapse.
Music listening is widely used as a sleep aid. A study from the Cochrane library shows consensus that music may be helpful to improve sleep quality in insomnia. It remains unclear if music listening is helpful to patients with depression as it is to a broader population.
A randomized controlled trial address the use of music as a supplementary treatment to improve sleep in depression.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Music intervention
Time frame: Change of sleep quality from baseline at 4 weeks
Questionnaire PSQI-DK on self reported sleep measuring subjective sleep quality, sleep latency, sleep duration, sleep disturbances, daytime dysfunctions and use of antidepressant agents
Time frame: Change of sleep quality from baseline at 8 weeks
Questionnaire PSQI-DK on self reported sleep measuring subjective sleep quality, sleep latency, sleep duration, sleep disturbances, daytime dysfunctions and use of antidepressant agents.
Time frame: Change of sleep quality from baseline at 4 weeks
Accelerometer Axivity Ax3 data logger carried as a hand wrist bracelet at night. A sleep analysis function by a generic algorithm provide data on sleep estimates.
Time frame: Change of sleep quality from baseline at 8 weeks
Accelerometer Axivity Ax3 data logger carried as a hand wrist bracelet at night. A sleep analysis function by a generic algorithm provide data on sleep estimates.
Time frame: Change of depression level from baseline at 4 weeks
The Hamilton Depression Rating Scale (HAM-D17). The scale consist of 17 items. Total score range is 0-52. Higher numbers represent more severe symptoms.
Time frame: Change of depression level from baseline at 8 weeks
The Hamilton Depression Rating Scale (HAM-D17). The scale consist of 17 items. Total score range is 0-52. Higher numbers represent more severe symptoms.
Time frame: Change of quality of life from baseline at 4 weeks
The World Health Well-Being Index (WHO-5)
Time frame: Change of quality of life from baseline at 8 weeks
The World Health Well-Being Index (WHO-5)
Time frame: Change of quality of life from baseline at 4 weeks
The World Health Organization Quality of Life (WHOQOL-Bref)
Time frame: Change of quality of life from baseline at 8 weeks
The World Health Organization Quality of Life (WHOQOL-Bref)
Time frame: 4 week music intervention period
log file data on duration of music intervention
Aalborg University Hospital
Other
Music to Improve Sleep Quality in Adults With Depression and Insomnia: a Randomized Controlled Trial Using Mixed Methods
Acronym: MUSTAFI
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03673397
Behavior, Behavioral Symptoms
Sankt Gallen, Switzerland
View Trial DetailsNCT00949689
Behavior, Behavioral Symptoms
Berkeley, California, United States
View Trial DetailsNCT05041647
Behavior, Behavioral Symptoms
Hamilton, Ontario, Canada
View Trial DetailsNCT04424407
Anxiety Disorders, Behavior
Palo Alto, California, United States
View Trial Details